The deadline for compliance with the EU Falsified Medicines Directive is now less than two years away. Serialisation – assigning a unique identity to each pack – is proving to be the most challenging aspect of the Directive and indications are that a proportion of manufacturers may not be able to implement a robust serialisation strategy ahead of the deadline.

Thanks to its successful partnership with Optel Vision and TraceLink, Central Pharma is already delivering product serialisation compliant with the Falsified Medicines Directive and other similar schemes around the world.

Aimed at pharma production, packaging, engineering and project managers, this event will showcase key learnings from each of the project partners' perspectives, along with recommendations to help your own serialisation initiatives run smoothly. The day will also feature tours of Central Pharma's facility and the opportunity to see serialisation in action.

The event is free to attend but places are limited, so please register early to avoid disappointment.